CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam

GlobalData
109 Pages - GLDATA68597
$1,995.00

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Vietnam.

It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Vietnam. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Vietnam, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (DHG Pharma, Traphaco, GSK, Domesco and Sanofi) and profiles and SWOT analyses of the major player in the medical device market (Terumo)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Vietnam.
- Porter’s five forces analysis for pharmaceutical and medical devices market of Vietnam.
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Vietnamese healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Vietnamese healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Vietnamese healthcare market

'

Table of Contents
1.1 List of Figures
1.2 List of Tables
2 Executive Summary
2.1 Executive Summary - Overview
2.2 Key Highlight: Vietnam
2.3 Key Events: Vietnam Healthcare History, 2012-2018
2.4 Key Events: Vietnamese Pharmaceutical Market
2.5 Key Events: M&A, VF & PE Deals, Pharmaceutical Market Global, 2018-2019
2.6 Key Events: Mergers and Acquisitions
2.7 Country Profile, Vietnam, 2018
3 Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels
3.5 Pharmaceutical Market - Market Segments
3.6 Pharmaceutical Market - Major Therapeutic Areas
3.7 Pharmaceutical Market - Major Players
4 Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Device Market - Major Players
5 Pharmaceutical and Medical Device Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6 Deal Analysis
6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Vietnam, 2018-2019
6.2 Deal Analysis: M&A, VF and PE Deals, Medical Device Market, Vietnam, 2018-2019
7 Pharmaceutical and Medical Device Market - Porter’s Five Forces Analysis
7.1 Pharmaceutical Market, Vietnam - Porter’s Five Forces Analysis
7.2 Medical Device Market, Vietnam - Porter’s Five Forces Analysis
8 Market Access
8.1 Reimbursement Landscape, Vietnam
8.1.1 Overview of Healthcare System, Vietnam
8.1.2 Reimbursement Process, Vietnam
8.1.3 Overview of Insurance Providers, Vietnam
8.1.4 Healthcare Spending and Price Trends, Vietnam
8.1.5 Pricing Policies, Vietnam
8.2 Regulatory Landscape, Vietnam
8.2.1 Overview of Regulatory Agencies, Vietnam
8.2.2 Market Authorization for Pharmaceutical Products (National Procedure), Vietnam
8.2.3 Market Authorization for New Drug Application, Vietnam
8.2.4 Market Authorization for Generic Drugs, Vietnam
8.2.5 Market Authorization for Medical Devices, Vietnam
8.2.6 Licensing Process for Pharmaceutical and Medical Device Manufacturing, Vietnam
8.2.7 Intellectual Property Rights, Patent, Vietnam
8.2.8 Intellectual Property Rights, Trademark, Vietnam
8.2.9 Clinical Trial Regulation Process, Vietnam
8.2.10 Pharmaceutical Advertising Regulations, Vietnam
8.2.11 Pharmacy Regulations, Vietnam
8.2.13 Labeling and Packaging Regulations, Vietnam
9 Country Healthcare Landscape
9.1 Vietnam Healthcare Policy Highlights
9.2 Healthcare Facilities, Vietnam
9.3 Life Expectancy and Immunization Rate, Vietnam
9.4 Environmental Health, Vietnam
9.6 Disease Burden, Vietnam
9.7 Healthcare Personnel, Vietnam
9.8 Healthcare Expenditure, Vietnam
10 Trade Associations
11 Trade Fairs
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.1.4 Expert Panel
13.2 Bibliography
13.3 Contact Us
13.4 Disclaimer

List of Tables
Table 1: Merger & Acquisition Deals, Medical Device Market, Vietnam, 2018-2019
Table 2: Patent Fees, Vietnam, 2018
Table 3: Trademark Fees, Vietnam, 2018

List of Figures
Figure 1: Pharmaceutical Market, Vietnam, Revenue ($B), 2011-2018
Figure 2: Medical Device Market, Vietnam, Revenue ($M), 2013-2018
Figure 3: Country Profile, Vietnam, 2018
Figure 4: Pharmaceutical Market, Vietnam, Revenue ($B), 2010-2018
Figure 5: Pharmaceutical Market, Vietnam, Revenue Forecast ($B), 2019-2022
Figure 6: Pharmaceutical Exports ($M), Vietnam, 2010-2017
Figure 7: Top Export Partners, Vietnam, 2017
Figure 8: Pharmaceutical Imports ($B), Vietnam, 2010-2017
Figure 9: Top Import Partners, Vietnam, 2017
Figure 10: Pharmaceutical Supply Chain, Vietnam, 2019
Figure 11: Pharmaceutical Market, Vietnam, Major Players, 2017-2018
Figure 12: Medical Device Market, Vietnam, Revenue ($M), 2010-2019
Figure 13: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Vietnam, 2018-2019
Figure 14:Deal Value and Deal Count Sub-types, Pharmaceutical Market, Vietnam, 2018-2019
Figure 15: Merger & Acquisitions Deals Therapy Areas by Deal Value( $M),Pharmaceutical Market, Vietnam, 2018-2019
Figure16: Merger & Acquisitions Deals Therapy Areas by Deal Count, Pharmaceutical Market, Vietnam, 2018-2019
Figure 17: Overview of Healthcare System, Vietnam, 2017
Figure 18: Structure of Health Insurance System, Vietnam, 2017
Figure 19: Out-of-Pocket Expenditure (% of Total Health Spending), Vietnam, 2010-2017
Figure 20:Change in Price Trend in Healthcare Sector (%), Vietnam , 2010-2017
Figure 21: Change in Price Trend in Healthcare Sector (%), Vietnam , 2010-2017
Figure 22: Drug Administration of Vietnam, Organizational Structure, 2018
Figure 23:Drug Registration Process, Vietnam, 2017
Figure 24: Market Authorization for New Drug Application, Vietnam, 2017
Figure 25: Market Authorization for Generic Drugs, Vietnam, 2017
Figure 26: Market Authorization for Medical Devices, Vietnam, 2018
Figure 27:Patent Approval Process, Vietnam, 2018
Figure 28: Trademark Registration Process, Vietnam, 2018
Figure 29: Clinical Trial Regulation Process, Vietnam, 2018
Figure 30: Hospitals and Regional Polyclinics (N, thousands), Vietnam, 2010-2017
Figure 31: Medical Service Units (N, thousands), Vietnam, 2010-2017
Figure 32: Hospital Beds, Regional Polyclinic (N, thousands), Vietnam, 2010-2017
Figure 33:Hospital Beds (N, thousands), Vietnam, 2010-2017
Figure 34:Life Expectancy (Years), Vietnam, 2010-2017
Figure 35:Immunization Rate (%), Vietnam, 2010-2017
Figure 36:Major Causes of Mortality, No. of Deaths (N, thousands), Vietnam, 2016
Figure 37:Major Causes of Male Mortality, No. of Deaths (N, thousands), Vietnam, 2016
Figure 38:Major Causes of Female Mortality, No. of Deaths (N, thousands), Vietnam, 2016
Figure 39:Disability-Adjusted Life Years by Major Disease (N, thousands), Vietnam, 2016
Figure 40: Physicians (per 1,000 population), Vietnam, 2010-2017
Figure 41: Nurses (Per 1,000 Population), Vietnam, 2011-2017
Figure 42: Midwives (Per 1,000 Population), Vietnam, 2011-2017
Figure 43: Pharmacists (Per 1,000 Population), Vietnam, 2011-2017
Figure 44:PM2.5 (µg per m3), Vietnam, 2010-2017
Figure 45: CO2 Emissions (mt), Vietnam, 2010-2017
Figure 46:Healthcare Expenditure (% of GDP), Vietnam, 2010-2016
Figure 47:Public-Private Share (%), Vietnam, 2010-2016

$1,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports